Global Custom Market Research Reports Provider Company

phone

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018

  • Published Date: 04 Jun 2018
  • Number of Pages: 150
  • Category: Healthcare and Medical
  • Country: Global
Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018

Summary

GlobalDatas Medical Devices sector report, Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018" provides an overview of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalDatas team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
Publisher Name : GlobalData

2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Overview 8
3 Products under Development 9
3.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development 9
3.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Segment 10
3.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Territory 11
3.4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Regulatory Path 13
3.5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Estimated Approval Date 14
3.6 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Ongoing Clinical Trials 15
4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products under Development by Companies 16
4.1 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Companies - Pipeline Products by Stage of Development 16
4.2 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development 17
5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Companies and Product Overview 19
5.1 3DT Holdings LLC Company Overview 19
5.2 Aachen Resonance GmbH Company Overview 20
5.3 Acrostak (Schweiz) AG Company Overview 21
5.4 AlviMedica Medical Technologies Inc. Company Overview 22
5.5 Andramed GmbH Company Overview 23
5.6 Atrium Medical Corp Company Overview 24
5.7 Bolton Medical Inc Company Overview 25
5.8 Boston Scientific Corp Company Overview 27
5.9 BrosMed Medical Co., Ltd Company Overview 32
5.10 Cordis Corp Company Overview 37
5.11 CorNova Inc Company Overview 38
5.12 Hatch Medical LLC Company Overview 41
5.13 Innovia LLC Company Overview 42
5.14 iVascular SLU Company Overview 43
5.15 Kaneka Corp Company Overview 44
5.16 Lithotech Medical Ltd Company Overview 46
5.17 Medtronic plc Company Overview 47
5.18 Meril Life Sciences Pvt Ltd Company Overview 48
5.19 MicroPort Scientific Corp Company Overview 51
5.20 Natec Medical Ltd Company Overview 53
5.21 QT Vascular Ltd Company Overview 54
5.22 QualiMed Innovative Medizinprodukte GmbH Company Overview 58
5.23 Sahajanand Medical Technologies Pvt Ltd Company Overview 59
5.24 Spectranetics Corp Company Overview 60
5.25 Terumo Interventional Systems Company Overview 62
5.26 VasoTech Inc. Company Overview 63
6 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters- Recent Developments 64
6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results 64
6.2 May 17, 2018: Mr. Jonathan Chen Promoted to Chief International Business Officer of MPSC 66
6.3 May 16, 2018: Boston Scientific Announces Schedule of Presentations at EuroPCR 2018 66
6.4 May 11, 2018: Terumo Appoints its U.S.-based Subsidiarys Associate as the Fifth Terumo Fellow 67
6.5 May 10, 2018: Neovasc Announces Results for the First Quarter 2018 68
6.6 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 71
6.7 May 04, 2018: Ross Harvey named new director of global Customer Support & Delivery at Cook Medical 72
6.8 Apr 26, 2018: Getinge publishes Interim Report for January-March 2018 72
6.9 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 72
6.10 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results 74
6.11 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 76
6.12 Mar 29, 2018: Foxtrot NC PTCA Gains Regulatory Approval in Malaysia 77
6.13 Mar 28, 2018: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017 77
6.14 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 81
6.15 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results 83
6.16 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros 83
6.17 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program 85
6.18 Feb 08, 2018: MicroPort Endovascular Hercules Series Products Gain Regulatory Approval in Colombia 86
6.19 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 87
6.20 Feb 08, 2018: MicroPort Signs Strategic Agreement with Neptunus Biotechnology 87
6.21 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 88
6.22 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results 89
6.23 Jan 30, 2018: United Health Products Issues Update on HemoStyp South Korea MFDS Application 91
6.24 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronics Greater China Region 91
6.25 Jan 29, 2018: Getinge Reported Net Sales Of SEK22,495 M In 2017 92
6.26 Jan 29, 2018: Terumo Integrates Two R&D Facilities in Silicon Valley to Accelerate Development of Innovative Medical Devices 93
6.27 Jan 25, 2018: Firefighter, Foxtrot Pro, and Foxtrot NC Gain Regulatory Approval in India 93
6.28 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 94
6.29 Jan 22, 2018: Neovasc Appoints Fred Colen As Chief Executive Officer 96
6.30 Jan 09, 2018: MicroPort Selected as "2017 China Innovative Medical Device Company" 97
6.31 Jan 09, 2018: MicroPort Awarded 2017 Shanghai Pilot Enterprise with Outstanding Innovation 98
6.32 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 98
7 Appendix 146
7.1 Methodology 146
7.2 About GlobalData 149
7.3 Contact Us 149
7.4 Disclaimer 149

List Of Tables

1.1 List of Tables
Table 1: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development 10
Table 2: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Segment 11
Table 3: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Territory 12
Table 4: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Regulatory Path 14
Table 5: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Estimated Approval Date 15
Table 6: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Ongoing Clinical Trials 16
Table 7: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Companies - Pipeline Products by Stage of Development 17
Table 8: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development 18
Table 9: 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 20
Table 10: Conductance Balloon Coronary Post-Dilatation Catheter - Product Status 20
Table 11: Conductance Balloon Coronary Post-Dilatation Catheter - Product Description 20
Table 12: Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
Table 13: VIAR - Product Status 21
Table 14: VIAR - Product Description 21
Table 15: Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview 22
Table 16: PTCA Balloon - Product Status 22
Table 17: PTCA Balloon - Product Description 22
Table 18: AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 19: ProHP - Product Status 23
Table 20: ProHP - Product Description 23
Table 21: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 24
Table 22: Zero-Profile PTCA Balloon - Product Status 24
Table 23: Zero-Profile PTCA Balloon - Product Description 24
Table 24: Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 25
Table 25: Coronary Stent Balloon Catheter - Product Status 25
Table 26: Coronary Stent Balloon Catheter - Product Description 25
Table 27: Bolton Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 28: Flash PTCA - Product Status 26
Table 29: Flash PTCA - Product Description 26
Table 30: Runner PTCA Balloon Catheter - Product Status 27
Table 31: Runner PTCA Balloon Catheter - Product Description 27
Table 32: Runner Slim PTCA - Product Status 27
Table 33: Runner Slim PTCA - Product Description 27
Table 34: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 28
Table 35: 1.2 Zulu PTCA - Product Status 28
Table 36: 1.2 Zulu PTCA - Product Description 28
Table 37: NC Zulu PTCA Post-Dilatation Catheter - Product Status 29
Table 38: NC Zulu PTCA Post-Dilatation Catheter - Product Description 29
Table 39: Next Generation PCB - Product Status 29
Table 40: Next Generation PCB - Product Description 29
Table 41: Zulu PTCA Pre-Dilatation Catheter - Product Status 30
Table 42: Zulu PTCA Pre-Dilatation Catheter - Product Description 30
Table 43: Boston Scientific Corp - Ongoing Clinical Trials Overview 31
Table 44: Next Generation PCB - Cutting Balloon Versus High Pressure Balloon for the Treatment of AV Graft Stenosis 32
Table 45: BrosMed Medical Co., Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
Table 46: Artimes Pro Low Profile Dilatation Catheter 1.0 mm - Product Status 33
Table 47: Artimes Pro Low Profile Dilatation Catheter 1.0 mm - Product Description 33
Table 48: Artimes Pro Low Profile Dilatation Catheter 1.25 mm - Product Status 34
Table 49: Artimes Pro Low Profile Dilatation Catheter 1.25 mm - Product Description 34
Table 50: BrosMed Medical Co., Ltd - Ongoing Clinical Trials Overview 35
Table 51: Artimes Pro Low Profile Dilatation Catheter 1.0 mm - Artimes Pro Low Profile 1.00mm and 1.25mm Dilatation Catheters for Pre-Dilatation of Stenosis and Occlusion in Patients With Symptomatic Ischemic Heart Disease 36
Table 52: Artimes Pro Low Profile Dilatation Catheter 1.25 mm - Artimes Pro Low Profile 1.00mm and 1.25mm Dilatation Catheters for Pre-Dilatation of Stenosis and Occlusion in Patients With Symptomatic Ischemic Heart Disease 37
Table 53: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 38
Table 54: Next Generation EMPIRA PTCA Balloon - Product Status 38
Table 55: Next Generation EMPIRA PTCA Balloon - Product Description 38
Table 56: CorNova Inc Pipeline Products & Ongoing Clinical Trials Overview 39
Table 57: FiberHalo SRM Post-Dilation Angioplasty Catheter - Product Status 39
Table 58: FiberHalo SRM Post-Dilation Angioplasty Catheter - Product Description 39
Table 59: FiberHalo SRM Pre-Dilation Angioplasty Catheter - Product Status 40
Table 60: FiberHalo SRM Pre-Dilation Angioplasty Catheter - Product Description 40
Table 61: FiberHalo SRM Stent Delivery Catheter - Product Status 40
Table 62: FiberHalo SRM Stent Delivery Catheter - Product Description 41
Table 63: Hatch Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 42
Table 64: Hydra Bifurcated Coronary Balloon Catheter - Product Status 42
Table 65: Hydra Bifurcated Coronary Balloon Catheter - Product Description 42
Table 66: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 43
Table 67: Low Profile Angioplasty Balloon Catheter - Product Status 43
Table 68: Low Profile Angioplasty Balloon Catheter - Product Description 43
Table 69: iVascular SLU Pipeline Products & Ongoing Clinical Trials Overview 44
Table 70: Scoring Balloon - Product Status 44
Table 71: Scoring Balloon - Product Description 44
Table 72: Kaneka Corp Pipeline Products & Ongoing Clinical Trials Overview 45
Table 73: Ikazuchi Zero - Product Status 45
Table 74: Ikazuchi Zero - Product Description 46
Table 75: Raiden 3 - Product Status 46
Table 76: Raiden 3 - Product Description 46
Table 77: Lithotech Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
Table 78: Scoring Balloon - Product Status 47
Table 79: Scoring Balloon - Product Description 47
Table 80: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 48
Table 81: Euphora Drug Coated Balloon - Product Status 48
Table 82: Euphora Drug Coated Balloon - Product Description 48
Table 83: Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
Table 84: MeRes100 - Product Status 49
Table 85: MeRes100 - Product Description 49
Table 86: Meril Life Sciences Pvt Ltd - Ongoing Clinical Trials Overview 50
Table 87: MeRes100 - A Prospective, Multinational, Multicenter, Single Arm, Open Label, Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System in the Treatment of De-novo Native Coronary Artery Lesions (MeRes-1 Extend) 51
Table 88: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 52
Table 89: Hercules-D - Product Status 52
Table 90: Hercules-D - Product Description 52
Table 91: Ryfle PTCA Balloon - Product Status 53
Table 92: Ryfle PTCA Balloon - Product Description 53
Table 93: Ryfle PTCA Balloon Catheter - Product Status 53
Table 94: Ryfle PTCA Balloon Catheter - Product Description 53
Table 95: Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 54
Table 96: NATEC Angioplasty Balloon - Product Status 54
Table 97: NATEC Angioplasty Balloon - Product Description 54
Table 98: QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
Table 99: Chocolate Touch PTCA Coronary Drug Coated Balloon - Product Status 55
Table 100: Chocolate Touch PTCA Coronary Drug Coated Balloon - Product Description 55
Table 101: Silk PTCA Balloon Catheter - Product Status 56
Table 102: Silk PTCA Balloon Catheter - Product Description 56
Table 103: QT Vascular Ltd - Ongoing Clinical Trials Overview 57
Table 104: Chocolate Touch PTCA Coronary Drug Coated Balloon - Clinical Study Evaluating the Chocolate Touch PTCA Coronary Drug-coated Balloon 58
Table 105: QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 59
Table 106: Biodegradable Balloon - Product Status 59
Table 107: Biodegradable Balloon - Product Description 59
Table 108: Sahajanand Medical Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 60
Table 109: Advanced Balloon Catheter - Product Status 60
Table 110: Advanced Balloon Catheter - Product Description 60
Table 111: Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 61
Table 112: CardioSculpt Valvuloplasty Scoring Balloon - Product Status 61
Table 113: CardioSculpt Valvuloplasty Scoring Balloon - Product Description 61
Table 114: Drug Coated Balloon - In-stent Restenosis (ISR) - Product Status 62
Table 115: Drug Coated Balloon - In-stent Restenosis (ISR) - Product Description 62
Table 116: Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 63
Table 117: PTCA Balloon - Product Status 63
Table 118: PTCA Balloon - Product Description 63
Table 119: VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
Table 120: DirectBalloon - Product Status 64
Table 121: DirectBalloon - Product Description 64
Table 122: Glossary 149

List Of Figures

1.2 List of Figures
Figure 1: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Stage of Development 10
Figure 2: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Segment 11
Figure 3: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Territory 12
Figure 4: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Regulatory Path 14
Figure 5: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products by Estimated Approval Date 15
Figure 6: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Ongoing Clinical Trials 16

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018 GlobalDatas Medical Devices sector report, Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Medical Devices Pipeline Assessment, 2018

View Report

Percutaneous Coronary Intervention Global Clinical Trials Review, H1, 2018 GlobalDatas clinical trial report, Percutaneous Coronary Intervention Global Clinical Trials Review, H1, 2018 provides an overview of Percutaneous Coronary Intervention clinical trials

View Report

In this report, the Global Tumor Ablation market was valued at USD 750.4 Million in 2015, and is projected to reach USD 2,129 Million by 2025, growing at a CAGR

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports